HLI vs RMD · P/E 22, rev $2.62B vs P/E 29, rev $5.65B
Houlihan Lokey Inc (HLI) versus ResMed Inc (RMD) — a side-by-side from cached financials, not a winner call.
Houlihan Lokey Inc (HLI) is a capital markets company listed on US.
ResMed Inc (RMD) is a medical instruments & supplies company listed on US.
Latest reported HLI revenue for 2026-03-31 was $2.62B. Net income was $425.7M. Revenue was up 9.5% from 2025-03-31 to 2026-03-31. HLI currently screens at market cap $9.62B and trailing P/E 22.4.
Latest reported RMD revenue for 2026-06-30 was $5.65B. Net income was $1.52B. Revenue was up 9.9% from 2025-06-30 to 2026-06-30. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
HLI currently screens at market cap $9.62B and trailing P/E 22.4. RMD currently screens at market cap $37.68B and trailing P/E 28.8.
Not investment advice. Open the HLI and RMD stock pages for the full models.
Not investment advice.